Education
About Us
Working with TipRanks
Follow Us
Aquestive Therapeutics (AQST)
NASDAQ:AQST
AQST Analyst Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AQST Stock 12 Month Forecast
Average Price Target
$7.68
▲(222.69% Upside)
| Highest Price Target$10.00 | Average Price Target$7.68 | Lowest Price Target$4.75 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Best Analysts Covering Aquestive Therapeutics
Which Analyst Should I Follow If I Want to Buy AQST and Sell After:
1 Month
xxx
Success Rate
20/36 ratings generated profit
Average Return
+4.91%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +4.91% per trade.
3 Months
xxx
Success Rate
8/16 ratings generated profit
Average Return
+13.99%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +13.99% per trade.
1 Year
Success Rate
16/36 ratings generated profit
Average Return
+36.48%
reiterated a buy rating 2 months ago
Copying Jason Butler's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +36.48% per trade.
2 Years
xxx
Success Rate
18/36 ratings generated profit
Average Return
+68.53%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +68.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AQST Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
12
10
13
13
16
Buy
2
2
1
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
12
14
14
17
Each month's total comprises the sum of three months' worth of ratings.
AQST Financial Forecast
AQST Stock Forecast FAQ
What is AQST’s average 12-month price target, according to analysts?
Based on analyst ratings, Aquestive Therapeutics’s 12-month average price target is 7.68.
What is AQST’s upside potential, based on the analysts’ average price target?
Aquestive Therapeutics has 222.69% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AQST a Buy, Sell or Hold?
Aquestive Therapeutics has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Aquestive Therapeutics’s price target?
The average price target for Aquestive Therapeutics is 7.68. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.00 ,the lowest forecast is $4.75. The average price target represents 222.69% Increase from the current price of $2.38.
The highest analyst price target is $10.00 ,the lowest forecast is $4.75. The average price target represents 222.69% Increase from the current price of $2.38.
What do analysts say about Aquestive Therapeutics?
Aquestive Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of AQST?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.